InvestorsHub Logo
Followers 225
Posts 32268
Boards Moderated 3
Alias Born 10/10/2005

Re: jondoeuk post# 8

Friday, 05/28/2021 8:59:38 PM

Friday, May 28, 2021 8:59:38 PM

Post# of 41
Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at Truist Securities from a "hold" rating to a "buy" rating. They now have a $41.00 price target on the stock, up previously from $34.00.This represents a 64.3% upside from the current price of $24.96.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALLO News